A dual kinase inhibitor is entering a clinical trial for advanced pancreatic cancer in combination with gemcitabine.
Clearing up chemo options for frail and elderly patients with advanced oesophageal and stomach cancers
Older patients with advanced oesophageal and stomach cancers might benefit from low dose treatment, according to our unpublished clinical trial results.
Less chemotherapy is as effective at controlling some advanced cancers for elderly patients, according to results of a Cancer Research UK funded trial.
Scientists could help match cancer patients with no other treatment options to clinical trials with experimental medicines
Combining a targeted cancer drug with an immunotherapy extends the lives of advanced kidney cancer patients, according to two clinical trials.
The first clinical trial testing Owlstone’s Breath Biopsy® technology on a range of cancer types is now open.
Researchers are trying to diagnose lung cancer early through screening, and studying if the benefits of early detection outweigh the harms.
Restricting the ability of cancer cells to metabolise sugar could make oncolytic viruses more effective at attacking them.
Mirati Therapeutics, Inc. is the latest partner of Cancer Research UK’s Stratified Medicine Programme.